IP

Inter Pharma Public Company Limited

IP · BK · Healthcare / Biotechnology

4.90THB-0.02 (-0.41%)

Price History

Full chart

Market Stats

Previous Close4.92
Open4.96
Day Range4.90 – 4.96
52-Week Range3.38 – 5.65
Volume90.15K
Market Cap2.98B
P/E (TTM)21.39
Forward P/E0.00
EPS0.23
Dividend Yield1.48%
Beta0.37
50-Day Avg5.15
200-Day Avg4.52

About

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equipment and medicines, etc. It also provides pet healthcare and livestock products, such as medical supplies, nutrition therapy, vaccine, supplementary food, probiotic and prebiotic products, animal health food products, animal food, general formula animal food, nutraceuticals and medicine companion products, ear and teeth cleaners, pee pads, shampoos, and medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. It serves retail customers through distributors. The company was incorporated in 2006 and is headquartered in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Trinnawat Thanitnithiphan
  • Employees0
  • HeadquartersNo. 140/9 ITF Tower, Bangkok, Thailand, 10500, Thailand
  • Websitehttps://www.interpharma.co.th

Leadership

  • Dr. Trinnawat ThanitnithiphanCEO, Acting Chief of Marketing and Sales & Director · b. 1971
  • Ms. Napaporn DechakaratCOO & Director · b. 1976
  • Ms. Apimon PosriChief of Human Resources & Director · b. 1971
  • Ms. Chatkaew KrudkosolActing Chief of Financial & Accounting · b. 1970
  • Ms. Chompunuch MeevangCompany Secretary, Head of Investor Relations & Head of Compliance · b. 1973
  • Ms. Supaporn ChanwongngamAccounting Manager

Financials

Income Statement

Currency: THB2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue125.44M247.30M313.64M371.33M442.10M908.63M1.52B1.78B1.90B2.19B
Growth (%)-+97.15%+26.83%+18.39%+19.06%+105.53%+67.65%+16.93%+6.52%+15.61%
Cost of Revenue39.24M99.27M125.04M157.39M181.22M507.85M904.87M1.12B1.19B1.37B
Gross Profit86.20M148.02M188.60M213.94M260.88M400.78M618.46M659.44M710.02M820.52M
Gross Margin68.72%59.86%60.13%57.61%59.01%44.11%40.60%37.02%37.42%37.41%
Operating Expense58.82M119.39M147.64M152.40M182.54M255.01M446.76M550.04M634.49M649.11M
Operating Income27.38M28.64M40.96M61.54M78.33M145.77M171.70M109.40M75.53M171.40M
Operating Margin21.83%11.58%13.06%16.57%17.72%16.04%11.27%6.14%3.98%7.81%
EBITDA28.82M29.60M42.16M63.61M82.64M172.38M235.78M167.66M185.20M288.15M
EBITDA Margin22.98%11.97%13.44%17.13%18.69%18.97%15.48%9.41%9.76%13.14%
Net Income15.63M15.72M29.68M43.47M52.54M105.22M118.88M50.79M37.28M122.38M
Net Income Margin12.46%6.36%9.46%11.71%11.88%11.58%7.80%2.85%1.96%5.58%
Interest Expense-34.17K43.21K589.40K1.14M8.01M23.34M25.76M19.85M19.58M
Interest Expense % of Total Revenue-0.01%0.01%0.16%0.26%0.88%1.53%1.45%1.05%0.89%

Balance Sheet

Currency: THB2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets79.87M104.62M192.15M525.88M749.95M1.33B3.03B2.95B3.02B3.24B
Total Liabilities42.90M25.88M85.16M60.13M262.27M543.54M952.25M834.65M866.40M939.83M
Total Equity36.97M73.27M100.55M455.71M471.09M761.64M1.93B1.91B1.94B2.06B
Cash6.37M36.08M32.45M342.65M152.33M173.87M776.42M412.39M184.60M280.64M
Total Debt556.91K62.34K11.60M9.20M120.35M355.96M538.97M399.95M394.42M400.94M
Net Debt-5.81M-36.02M-20.85M-333.45M-31.98M182.09M-237.45M-12.44M209.82M120.30M

Cash Flow

Currency: THB2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow25.19M11.46M-6.19M5.03M-8.82M-41.57M143.09M121.42M177.84M289.12M
Investing Cash Flow-30.18M19.83M-7.58M-2.05M-249.73M-351.79M-588.13M-232.77M-310.01M-166.03M
Financing Cash Flow-127.09K-1.58M10.14M307.21M68.23M414.92M1.05B-252.86M-95.45M-26.95M
Capital Expenditure1.25M4.27M9.22M2.18M14.50M237.85M49.97M144.09M261.46M142.03M
Free Cash Flow23.94M7.19M-15.41M2.85M-23.32M-279.42M93.12M-22.67M-83.62M147.09M
Dividends Paid-36.40M28.00M11.57M38.02M4.83M4767.00M12.97M0
FCF to OCF95.03%62.76%248.94%56.63%264.47%672.10%65.08%-18.67%-47.02%50.88%
Dividend Paid to FCF-506.23%-181.74%405.81%-163.05%-1.73%0.00%-295.52%-15.50%0.00%

Earnings

Report DateNov 27, 2019Feb 24, 2020May 11, 2020Aug 16, 2020Nov 10, 2020Feb 24, 2021Jun 2, 2021Aug 12, 2021Nov 9, 2021Feb 24, 2022May 12, 2022Aug 10, 2022Nov 10, 2022Feb 27, 2023May 11, 2023Aug 10, 2023Nov 13, 2023Feb 29, 2024May 14, 2024Aug 14, 2024Nov 14, 2024Feb 25, 2025May 14, 2025Aug 15, 2025Nov 12, 2025Mar 4, 2026May 12, 2026Aug 17, 2026
EPS Estimate-------------0.09--------------
EPS Actual0.030.030.030.040.040.010.040.050.050.070.060.060.060.050.070.020.02-0.020.030.010.010.020.040.050.070.040.060.05
Surprise--------------44.44%--------------
Timing--After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours------

Key Statistics & Ratios

Market Cap2.98B
Enterprise Value3.18B
Trailing P/E21.39
Forward P/E0.00
Price / Sales1.32
Price / Book1.47
EPS0.23
Book Value3.44
Revenue (TTM)2.26B
Gross Profit (TTM)968.50M
EBITDA284.60M
Profit Margin6.11%
Operating Margin9.43%
Return on Equity6.85%
Return on Assets4.24%
Shares Outstanding605.34M
Shares Float290.47M
Beta0.37
Dividend Yield1.48%
Dividend Rate0.07
Payout Ratio32.03%

Dividends

20261×
0.07May 6, 2026
20241×
0.03May 7, 2024
20231×
0.11May 8, 2023
20211×
0.01Mar 11, 2021
20201×
0.08Apr 8, 2020

Stock Splits

  • May 7, 202413:8
  • Jul 20, 2021190:189
  • Mar 11, 20217:5